Author

Viviane Sonaglio

Observed name: Sonaglio, Viviane

Institution: AC Camargo Hospital

Observed institutions: Universidade de São Paulo, AC Camargo Hospital, Support group for adolescents and children with cancer, Centro Infantil Boldrini, Hospital Santa Marcelina, Hospital do Servidor Público Estadual, Universidade Federal de São Paulo

ORCID: 0009-0001-2866-0428

Observed ORCID: 0009-0001-2866-0428

OpenAlex ID: A5002651870

Cisplatin and Etoposide in Childhood Germ Cell Tumor: Brazilian Pediatric Oncology Society Protocol GCT-91

2009 · Luiz Fernando Lopes, Carla Renata Pacheco Macedo, et al. · Journal of Clinical Oncology · 47

Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group

2016 · Luiz Fernando Lopes, Carla Renata Pacheco Donato Macedo, et al. · Journal of Clinical Oncology · 26

Improvement in the outcome of children with germ cell tumors

2007 · Luiz Fernando Lopes, Viviane Sonaglio, et al. · Pediatric Blood & Cancer · 17

Consensus on Malignant and Benign Tumors in Pediatric Patients with Neurofibromatosis Type 1: On Behalf of the Brazilian Society of Pediatric Oncology (SOBOPE)

2025 · Luiz Guilherme Darrigo Junior, Viviane Sonaglio, et al. · Current Oncology · 1

Development of the pediatric version of the oral mucositis impact scale in oncology patients (EIMOPO-infantil) in Brazil

2026 · Gabriela Borges Saldys, Nayara Fernanda Pereira, et al. · Brazilian journal of oral sciences/Brazilian Journal of Oral Sciences

Impact of selumetinib on pain in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An in-depth analysis from KOMET

2026 · Said Farschtschi, Carolina Barnett-Tapia, et al. · Neuro-Oncology Practice

Neurofibromatosis type 1 in Brazil: Pediatric care in the Unified Health System

2026 · Viviane Sonaglio, Gabriela Oigman Bellas, et al. · European Journal of Medical Genetics

Adherence to the febrile neutropenia protocol in pediatric leukemia patients at a Brazilian Cancer Center—A retrospective audit

2025 · Jessica Talita Mariana Wicthoff Raniero, Anita Cassoli Cortez, et al. · Pediatric Hematology and Oncology

National Studies for Childhood Germ Cell: 1073 Patients. Intermediate Risk with Cisplatin/Etoposide (PE) and no Bleomycin. High Risk Good Responders (HR-GR) with Excellent Results

2018 · Luiz Fernando Lopes, C. R. Donato Macedo, et al.

Creating and developing games throughout interdisciplinarity and patient participation.

2017 · Simone Lehwess Mozzilli, Elisa Sassi, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 91

H-index: 3

I10-index: 3